CN Stock MarketDetailed Quotes

600211 Tibet Rhodiola Pharmaceutical Holding

Watchlist
  • 36.07
  • +0.03+0.08%
Market Closed Jan 20 15:00 CST
11.63BMarket Cap15.76P/E (TTM)

Tibet Rhodiola Pharmaceutical Holding Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tibet Rhodiola Pharmaceutical Holding Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.070B--
--2024/FY-- / 3.438B--
Mar 27, 20242023/FY3.134B / 3.506B--
Mar 13, 20202019/FY1.256B / 1.380B--
--------

Unlock Free Earnings Estimates

Tibet Rhodiola Pharmaceutical Holding Earnings Reports

  • Tibet Nordicang Pharmaceutical Co., Ltd. Report for the third quarter of 2024

    Oct 29, 2024 12:00 ET

  • Tibet Rhodiola Pharmaceutical Holding Semi-annual Report for 2023

    Aug 13, 2024 12:00 ET

  • Summary of Tibet Rhodiola Pharmaceutical Holding's H1 2024 report.

    Aug 13, 2024 12:00 ET

  • Tibet Pharmaceutical Report for the First Quarter of 2024

    Apr 26, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 20, 2025

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Brain science (brain-computer interface)
    Brain science (brain-computer interface)
    Intraday+1.71%
    Biomedical
    Biomedical
    Intraday+1.50%
    Medical Device Concept
    Medical Device Concept
    Intraday+0.86%